ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
実験式（ヒル表記法）:
C16H19N3O4S
CAS番号:
分子量:
349.40
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
1090925
製品名
アンピシリン, anhydrous, European Pharmacopoeia (EP) Reference Standard
InChI
1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1
SMILES string
[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)c3ccccc3)C(O)=O
InChI key
AVKUERGKIZMTKX-NJBDSQKTSA-N
grade
pharmaceutical primary standard
API family
ampicillin
quality
anhydrous
manufacturer/tradename
EDQM
mp
208 °C (dec.) (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
類似した製品をお探しですか？ 訪問 製品比較ガイド
関連するカテゴリー
Biochem/physiol Actions
作用機序：半合成のペニシリンであるアンピリシンは、細菌の細胞膜の内面でトランスペプチダーゼを失活させることによって細菌の細胞壁の合成を阻害するβ-ラクタムです。
耐性機序：β-ラクタマーゼを投与するとアンピシリンのラクタム環が開裂し、それを失活させます。
抗菌スペクトル：グラム陽性細菌（ベンジルペニシリンと同様）およびグラム陰性細菌（テトラサイクリンおよびクロラムフェニコールと同様）の両方に対して有効です。
耐性機序：β-ラクタマーゼを投与するとアンピシリンのラクタム環が開裂し、それを失活させます。
抗菌スペクトル：グラム陽性細菌（ベンジルペニシリンと同様）およびグラム陰性細菌（テトラサイクリンおよびクロラムフェニコールと同様）の両方に対して有効です。
Application
Ampicillin EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
signalword
Danger
hcodes
Hazard Classifications
Resp. Sens. 1 - Skin Sens. 1
保管分類
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Arnaud Taton et al.
Nucleic acids research, 42(17), e136-e136 (2014-07-31)
Inspired by the developments of synthetic biology and the need for improved genetic tools to exploit cyanobacteria for the production of renewable bioproducts, we developed a versatile platform for the construction of broad-host-range vector systems. This platform includes the following
Kristofor K Ellestad et al.
European journal of immunology, 44(12), 3560-3572 (2014-09-23)
The expression of the coinhibitor PD-1 on T cells is important for the establishment of immune homeostasis. We previously found that PD-1 is particularly critical for the control of self-tolerance during lymphopenia-induced proliferation of recent thymic emigrants (RTEs). Previous studies
Jens T Van Praet et al.
The EMBO journal, 34(4), 466-474 (2015-01-21)
Antinuclear antibodies are a hallmark feature of generalized autoimmune diseases, including systemic lupus erythematosus and systemic sclerosis. However, the processes underlying the loss of tolerance against nuclear self-constituents remain largely unresolved. Using mice deficient in lymphotoxin and Hox11, we report
Marcel Weber et al.
PloS one, 9(6), e100000-e100000 (2014-06-21)
Several synthetic antibody phage display libraries have been created and used for the isolation of human monoclonal antibodies. The performance of antibody libraries, which is usually measured in terms of their ability to yield high-affinity binding specificities against target proteins
Diana D Semler et al.
Antimicrobial agents and chemotherapy, 58(7), 4005-4013 (2014-05-07)
Phage therapy has been suggested as a potential treatment for highly antibiotic-resistant bacteria, such as the species of the Burkholderia cepacia complex (BCC). To address this hypothesis, experimental B. cenocepacia respiratory infections were established in mice using a nebulizer and
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）